Neutrophil Activation and Adhesiveness in Coronary Artery Disease: Results From the COLCHICINE-PCI Biomarker Substudy
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Registration URL: https://clinicaltrials.gov. Unique identifier: NCT02594111.
References
1.
Nidorf S, Fiolet A, Mosterd A, Eikelboom J, Schut A, Opstal T
. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020; 383(19):1838-1847.
DOI: 10.1056/NEJMoa2021372.
View
2.
Banco D, Mustehsan M, Shah B
. Update on the Role of Colchicine in Cardiovascular Disease. Curr Cardiol Rep. 2024; 26(4):191-198.
DOI: 10.1007/s11886-024-02026-5.
View
3.
Shah B, Pillinger M, Zhong H, Cronstein B, Xia Y, Lorin J
. Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial. Circ Cardiovasc Interv. 2020; 13(4):e008717.
PMC: 7169992.
DOI: 10.1161/CIRCINTERVENTIONS.119.008717.
View
4.
Tardif J, Kouz S, Waters D, Bertrand O, Diaz R, Maggioni A
. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019; 381(26):2497-2505.
DOI: 10.1056/NEJMoa1912388.
View
5.
Cronstein B, Molad Y, Reibman J, Balakhane E, Levin R, Weissmann G
. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest. 1995; 96(2):994-1002.
PMC: 185287.
DOI: 10.1172/JCI118147.
View